Apotea AB Statistics
Total Valuation
Apotea AB has a market cap or net worth of SEK 6.29 billion. The enterprise value is 6.61 billion.
| Market Cap | 6.29B |
| Enterprise Value | 6.61B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apotea AB has 104.07 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Current Share Class | 104.07M |
| Shares Outstanding | 104.07M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 62.74% |
| Float | 73.29M |
Valuation Ratios
The trailing PE ratio is 27.52 and the forward PE ratio is 24.00.
| PE Ratio | 27.52 |
| Forward PE | 24.00 |
| PS Ratio | 0.87 |
| PB Ratio | 7.32 |
| P/TBV Ratio | 7.87 |
| P/FCF Ratio | 51.85 |
| P/OCF Ratio | 18.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.16, with an EV/FCF ratio of 54.45.
| EV / Earnings | 28.90 |
| EV / Sales | 0.92 |
| EV / EBITDA | 14.16 |
| EV / EBIT | 21.72 |
| EV / FCF | 54.45 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.28 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.71 |
| Debt / FCF | 2.73 |
| Interest Coverage | 25.37 |
Financial Efficiency
Return on equity (ROE) is 30.26% and return on invested capital (ROIC) is 21.31%.
| Return on Equity (ROE) | 30.26% |
| Return on Assets (ROA) | 10.55% |
| Return on Invested Capital (ROIC) | 21.31% |
| Return on Capital Employed (ROCE) | 27.45% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.91M |
| Profits Per Employee | 314,580 |
| Employee Count | 724 |
| Asset Turnover | 3.99 |
| Inventory Turnover | 9.55 |
Taxes
In the past 12 months, Apotea AB has paid 63.50 million in taxes.
| Income Tax | 63.50M |
| Effective Tax Rate | 21.91% |
Stock Price Statistics
The stock price has decreased by -24.06% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.06% |
| 50-Day Moving Average | 81.42 |
| 200-Day Moving Average | 91.60 |
| Relative Strength Index (RSI) | 26.49 |
| Average Volume (20 Days) | 688,969 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Apotea AB had revenue of SEK 7.21 billion and earned 228.70 million in profits. Earnings per share was 2.20.
| Revenue | 7.21B |
| Gross Profit | 1.41B |
| Operating Income | 304.40M |
| Pretax Income | 289.80M |
| Net Income | 228.70M |
| EBITDA | 398.20M |
| EBIT | 304.40M |
| Earnings Per Share (EPS) | 2.20 |
Balance Sheet
The company has 30.60 million in cash and 331.00 million in debt, with a net cash position of -300.40 million or -2.89 per share.
| Cash & Cash Equivalents | 30.60M |
| Total Debt | 331.00M |
| Net Cash | -300.40M |
| Net Cash Per Share | -2.89 |
| Equity (Book Value) | 859.90M |
| Book Value Per Share | 8.11 |
| Working Capital | 247.00M |
Cash Flow
In the last 12 months, operating cash flow was 333.30 million and capital expenditures -211.90 million, giving a free cash flow of 121.40 million.
| Operating Cash Flow | 333.30M |
| Capital Expenditures | -211.90M |
| Free Cash Flow | 121.40M |
| FCF Per Share | 1.17 |
Margins
Gross margin is 19.52%, with operating and profit margins of 4.22% and 3.17%.
| Gross Margin | 19.52% |
| Operating Margin | 4.22% |
| Pretax Margin | 4.02% |
| Profit Margin | 3.17% |
| EBITDA Margin | 5.53% |
| EBIT Margin | 4.22% |
| FCF Margin | 1.68% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.52% |
| Shareholder Yield | -0.53% |
| Earnings Yield | 3.63% |
| FCF Yield | 1.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Apotea AB has an Altman Z-Score of 9.83 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.83 |
| Piotroski F-Score | 6 |